Capital to fund initiation of the first clinical trial of eAUS in patients suffering from stress urinary incontinence caused by sphincter insufficiency.
Capital will finance completion of preclinical studies and initiation of the first clinical trial in patients suffering from stress urinary incontinence.
Acquisition will add to TE’s integrated sensor solutions offering in medical, transportation, and industrial applications for a wide range of global customers.